WallStreetZenWallStreetZen

NASDAQ: MESO
Mesoblast Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MESO past revenue growth

How has MESO's revenue growth performed historically?
Company
-26.54%
Industry
104.93%
Market
14.21%
MESO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MESO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MESO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MESO earnings and revenue history

Current Revenue
$7.5M
Current Earnings
-$81.9M
Current Profit Margin
-1,091.7%

MESO Return on Equity

Current Company
-16.3%
Current Industry
1.3%
Current Market
-0.3%
MESO's Return on Equity (-16.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MESO announces earnings.

MESO Return on Assets

Current Company
-12.3%
Current Industry
-1.5%
MESO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MESO Return on Capital Employed

Current Company
-9.88%
Current Industry
11.8%
MESO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MESO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MESO$7.50M-$61.98M-$81.89M-15.43%N/A
INZY$0.00-$66.87M-$68.17MN/AN/A
FENC$13.05M-$17.00M-$20.22M+776.22%N/A
DRTSN/AN/AN/AN/AN/A
IMMP$3.29M-$25.24M-$25.25M-8.02%N/A
View Top Biotech Stocks

Mesoblast Earnings & Revenue FAQ

What were MESO's earnings last quarter?

On Invalid Date, Mesoblast (NASDAQ: MESO) reported Q2 2023 earnings per share (EPS) of -$0.14, up 15.15% year over year. Total Mesoblast earnings for the quarter were -$21.92 million. In the same quarter last year, Mesoblast's earnings per share (EPS) was -$0.17.

If you're new to stock investing, here's how to buy Mesoblast stock.

What was MESO's earnings growth in the past year?

As of Q4 2023, Mesoblast's earnings has grown year over year. Mesoblast's earnings in the past year totalled -$81.89 million.

What was MESO's revenue last quarter?

On Invalid Date, Mesoblast (NASDAQ: MESO) reported Q2 2023 revenue of $2.14 million up 3.82% year over year. In the same quarter last year, Mesoblast's revenue was $2.22 million.

What was MESO's revenue growth in the past year?

As of Q4 2023, Mesoblast's revenue has grown -26.54% year over year. This is 131.47 percentage points lower than the US Biotechnology industry revenue growth rate of 104.93%. Mesoblast's revenue in the past year totalled $7.50 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.